Valeant Pharmaceuticals' Bausch + Lomb Receives FDA Clearance for New SiHy Monthly Contact Lenses


LAVAL, Quebec—Valeant Pharmaceuticals International, Inc. and Bausch + Lomb have announced the FDA clearance of Bausch + Lomb’s newest frequent replacement silicone hydrogel contact lenses. The contact lenses, made with Bausch + Lomb’s MoistureSeal Technology, represent the category’s first new innovation in seven years, the company said. Bausch + Lomb’s previous notable product launches have included Biotrue ONEday contact lenses and Biotrue Multi-Purpose Solution.
“We are encouraged to receive this significant marketing clearance much sooner than originally expected,” stated J. Michael Pearson, chairman and chief executive officer of Valeant.  “When paired with Biotrue ONEday—our premium daily disposable contact lenses launched last year—we believe this new technology will begin to build an improved contact lens business by providing contact lens wearers with unsurpassed comfort and vision throughout the day.”
The new lenses are only available with a prescription from an eyecare professional.